Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks
Year: 2022
Type: article
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Foundation of the American College of Allergy, Asthma & Immunology, Patient-Centered Outcomes Research Institute, National Institutes of Health, Agency for Healthcare Research and Quality, American Academy of Allergy, Asthma and Immunology Foundation, National Health and Medical Research Council, National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: G129402337, G1475387526, G1991070941, Stevens-Johnson syndrome/toxic epidermal necrolysis 2021: Collaboration, Innovation and Community, Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors, Immune Tolerance Network, Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study), NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
OpenAlex ID: W4282947347
